Skip to main content

Day: May 20, 2020

BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing

PATTERSON, N.J., May 20, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced the appointment of Christopher Boyer as Vice President of Global Marketing.  Mr. Boyer will be responsible for worldwide marketing activities with a focus on expanding BrainsWay’s market share, leading the corporate go-to-market strategy, and overseeing the continued development of the BrainsWay brand.  He has more than 15 years of medical device marketing and business development experience in both privately-held and multi-billion dollar publicly-held medical device companies.“Chris is a seasoned marketing executive in the medical device industry, and we are pleased to welcome him to our senior leadership team,” said...

Continue reading

Auxly Announces Receipt of Sales Licence for Premium Craft Cannabis Brand Robinsons

TORONTO, May 20, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, is pleased to announce that its wholly owned subsidiary Robinsons Cannabis Inc. (“Robinsons”) has been authorized by Health Canada to sell dried cannabis to provinces and territories under the Cannabis Regulations. This sales licence expands Auxly’s product portfolio to include artisan hand-crafted cannabis flower for the premium craft market, which the Company expects to be available in select Canadian provinces this summer.“We couldn’t be more excited to obtain this sales licence for Robinsons – a key milestone for Auxly as we continue to execute against our vision of being a leader in branded cannabis products,” said Hugo Alves, CEO of...

Continue reading

Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

DUBLIN, Ireland and TREVOSE, Pa., May 20, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it and its subsidiaries have entered into a $30 million debt facility with Avenue Venture Opportunities Fund, L.P. (Avenue), a fund within the Avenue Capital Group, and its affiliates.“This new debt facility flexibly increases our cash position at an attractive cost. We are pleased to be partnering with Avenue Venture Opportunities Fund, and we appreciate their overall confidence in our clinical development program for RECORLEV® (levoketoconazole) and the commercial progress and potential of KEVEYIS® (dichlorphenamide),” said John H. Johnson,...

Continue reading

Radient Technologies Announces $5 Million Equity Offering

EDMONTON, Alberta, May 20, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce a proposed offering of 25,000,000 units (the “Units”) at an offering price of $0.20 per Unit (the “Issue Price”), for aggregate gross proceeds of up to $5,000,000 (the “Offering”). The Units will be offered on a best efforts basis by Eight Capital, as agent for the Company (the “Agent”), pursuant to a prospectus supplement to Radient’s base shelf prospectus dated January 21, 2020 (collectively, the “Prospectus”). BDO Canada LLP is acting as Radient’s financial advisor in connection with the Offering.Each Unit will be comprised of one common share in the capital of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant will entitle...

Continue reading

Enthusiast Gaming Announces Partnership Between The Vancouver Titans and Pizza Hut Canada

TORONTO, May 20, 2020 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX)(OTCQB: ENGMF)(FSE: 2AV) is excited to announce that the Vancouver Titans have entered into a new partnership agreement with Pizza Hut Canada designating Pizza Hut as the Official Pizza of the team and their fans.“We are incredibly thrilled to deliver this exciting partnership to our fans and can’t wait to make Pizza Hut an integral part of the Titans gameday experience,” said Tim Holloway, Esports Director at the Vancouver Titans.   “At Pizza Hut it’s no secret that we like to have fun with innovative ideas. We are a brand that is built of memories of togetherness,” said Devon Lawrence, Portfolio Marketing Manager at Pizza Hut Canada. “We see esports as a great opportunity to connect and make more memories...

Continue reading

Primoris Services Corporation Announces Industrial Awards Valued Over $62 million

DALLAS, May 20, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two new industrial awards with a combined value over $62 million. The contracts were secured by Primoris Industrial Constructors, part of the Power, Industrial, and Engineering segment. The first award is for the construction of the outside the battery limits (“OSBL”) portion of a renewable diesel expansion project in Louisiana. The scope includes civil, mechanical, structural, and electrical work. The project was designed by Primoris Design & Construction under a separate contract, and Primoris Industrial Constructors will coordinate with Primoris Design & Construction to ensure an efficient engineering and construction interface. Work is scheduled to commence in the second quarter...

Continue reading

Kitov Announces U.S. Commercial Launch of Consensi™

TEL AVIV, Israel, May 20, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced the U.S. commercial launch of Consensi™, a fixed-dose combination of celecoxib and amlodipine besylate, designed for the simultaneous treatment of hypertension and osteoarthritis pain. Consensi™ is being sold in the U.S. by Burke Therapeutics, the marketing partner of Kitov’s U.S. distributor, Coeptis Pharmaceuticals.“Consensi™ provides a new therapeutic option for patients suffering from both hypertension and osteoarthritis-related pain. We are excited about the availability of Consensi™ for patients”, said Dave Mehalick, Chief Executive Officer of Coeptis Pharmaceuticals.“We are please Consensi™ is now available...

Continue reading

Constellation Software Inc. Reaches Agreement to combine its TSS Operating Group With Topicus.com to form a new Operating Group

TORONTO, May 20, 2020 (GLOBE NEWSWIRE) — Constellation Software Inc. (“Constellation”) (TSX:CSU) announced today that it has, acting through its TSS operating group and its subsidiary TPCS Holding B.V. (the “Purchaser”), entered into a binding agreement with IJssel B.V. (the “Seller”) to purchase 100% of the shares of Topicus.com B.V. (“Topicus”), a Netherlands-based diversified vertical market software provider.  Once the transaction is completed, TSS and Topicus will operate together under the operating group name “Topicus.com”. Under the guidance of Constellation, Topicus.com intends to explore opportunities for a future public listing of its shares.  Pursuant to such listing, it is anticipated that Constellation would remain a significant shareholder of Topicus.com, and that the current Constellation shareholders would be entitled...

Continue reading

Surface Oncology Fully Utilizes its $30M At-the-Market Facility

CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) — Surface Oncology  (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today that it has raised gross proceeds of approximately $28.9 million through its At-the-Market, or ATM, facility with participation based on interest received from EcoR1 Capital LLC, Venrock Healthcare Capital Partners, BVF Partners L.P., and RS Investments, a Victory Capital investment franchise.  Surface Oncology sold approximately 10.9 million shares of its common stock at a purchase price of $2.66, the market price at the time of the sale.  This transaction exhausts the balance on the $30 million ATM facility. JonesTrading Institutional Services LLC is acting as the sales agent for the ATM facility.These funds...

Continue reading

Sodexo launches “Rise with Sodexo”, a global program to support organizations in their adaptation to the new normal

   Paris, May 20, 2020 – Sodexo, World Leader in Quality of Life services announced today the global launch of “Rise with Sodexo“, a program intended for its clients to meet the health, operational and confidence challenges as a result of the worldwide global COVID-19 pandemic.As many countries emerge progressively from confinement, employees expect to feel safe within the workplace and cared for when remote working, and consumers want to make sure they can count on the companies they trust to adopt the highest Health & Safety standards.In this context, convinced the value of our expertise and services, and our commitment in Corporate Responsibility are essential to regain trust in this extremely volatile environment, Sodexo developed “Rise with Sodexo” to help our clients resume, adapt and thrive each day with a comprehensive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.